NOVEL TECHNOLOGIES FOR NONINVASIVE DETECTION, DIAGNOSIS AND TREATMENT OF CANCER

Release Date:  December 10, 2001

NOTICE:  NOT-CA-02-004

National Cancer Institute

The Unconventional Innovations Program (UIP) of the National Cancer 
Institute (NCI) is seeking revolutionary technologies for cancer 
research.  The UIP is soliciting proposals for the development of 
multifunctional technology platforms to support minimally intrusive 
approaches that integrate: a) sensing of the fundamental signatures of 
precancers, or early, metastatic, or recurring cancers in the living 
body, b) transmission of signature information to an external monitor, 
c) controlled, specific, treatment, d) monitoring of the effects of 
treatment.  The UIP particularly seeks technology platforms that 
integrate novel approaches to signature recognition, signal generation, 
signal amplification, signal transmission, intervention delivery, 
intervention feedback, and data interpretation.  Proposals are 
encouraged from investigators from a variety of disciplines including, 
but not limited to, biomedical research, chemistry, physics, 
engineering, and computational sciences, particularly as 
multidisciplinary teams.  The detailed Broad Agency Announcement (RFP: 
N01-CO-27031-16) is available on the web site of the Research Contracts 
and Acquisition Branch, NCI at:  
http://rcb.nci.nih.gov/appl/rfp/published_rfps.jsp with instructions 
for submission of proposals and evaluation criteria.

INQUIRIES

For further information, contact:

Annmarie L. Keane
Contract Specialist
Treatment, Biology, and Sciences Section, RCB
Executive Plaza South
6120 Executive Blvd.
Rockville, MD  20892-7220
e-mail:  ak155a@nih.gov
voice:  301-496-8620
fax:  301-402-6699

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

			Department of Health and Human Services (HHS)
NIH... Turning Discovery Into Health®